<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02824237</url>
  </required_header>
  <id_info>
    <org_study_id>PR-15111</org_study_id>
    <secondary_id>1U01TW010120-01</secondary_id>
    <nct_id>NCT02824237</nct_id>
  </id_info>
  <brief_title>GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes</brief_title>
  <official_title>Bangladesh Center for Global Environmental and Occupational Health: A Study of Effects of Household Air Pollution on Cardio-pulmonary and Immune Function Outcomes Among Nonsmokers and Their Potential Prevention Avenues in Rural Bangladesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>York University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UChicago Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bangladesh Atomic Energy commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Centre for Diarrhoeal Disease Research, Bangladesh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      The increasing effect of environmental, occupational and climate change poses serious global
      threat for public health. More than half of the world's population, including around 85%
      people in Bangladesh, are exposed to household air pollutants (HAP). Environmental
      consequences of climate change are among the highest. Little evidence is available on the
      effects HAP on cardiopulmonary outcomes in low-income populations. Same is true for
      occupational health and climate change. The investigators will evaluate the effects of HAP on
      cardio-pulmonary and markers of immune function among non-smoking individuals. The
      investigators will also conduct two pilot studies to explore health effects associated with
      working in the garments industry and that of temperature due to climate changes.

      Hypothesis:

        1. Preclinical measures of cardiovascular diseases and pulmonary function are associated
           with exposure level of house hold air pollution (HAP) (assessed through PM2.5, CO and BC
           concentrations)

        2. Stable biomarkers of immune function and inflammation are associated with exposure level
           of HAP.

        3. Use of improved cook stove reduces exposure to HAP and thereby improve pre-clinical and
           molecular measures of cardio-pulmonary and immune functions.

      Methods: The investigators will conduct a cross sectional study to assess the associations of
      HAP with preclinical makers of CVD among 600 non-smoking participants aged 25 to 65 years.
      Biomass exposure will be assessed for PM2.5, carbon Monoxide (CO) and black carbon (BC) by
      collecting personal air samples for 24-hour. Blood sample will be utilized from a subset of
      200 adult participants and 60 children aged 3-5 years for assessing immune markers. The study
      will be conducted in icddr,b and URB study site at Matlab and Araihazar respectively.

      After the cross sectional assessment, the investigators will conduct a pre-post intervention
      study to evaluate effectiveness of improved stoves in a subset of 200 homes. The
      investigators will measure the aforementioned markers after two years of cook stove
      installation. Finally, as pilot studies, health outcomes due to climate change (temperature
      change) and occupation (garment industry work) will be explored.

      Outcome measures:

      HAP will be assessed through PM2.5, CO and BC concentrations. Pulmonary function will be
      assessed through FEV1, FVC and FEV1/FVC. Preclinical makers of CVD will include RH-PAT, FMD,
      IMT, BAD, EKG and PFT. Markers of Immune function - proliferation of macrophage, dendritic
      cells (DC), neutrophils and T-cell, as well as macrophage derived cytokines (a panel of 17 or
      27 cytokines) in peripheral blood mononuclear cells (PBMC)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2017</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PM2.5</measure>
    <time_frame>Two Years</time_frame>
    <description>The investigators will measure pre and post Changes in particulate matter &lt;2.5 micrometers exposure (PM2.5) through 24-hour personal monitoring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CO</measure>
    <time_frame>Two Years</time_frame>
    <description>The investigators will measure pre and post Changes in carbon monoxide (CO) exposure through 24-hour personal monitors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1</measure>
    <time_frame>Two Years</time_frame>
    <description>The investigators will measure pre post changes in Forced Expiratory Volume in 1 second (FEV1) by spirometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FVC</measure>
    <time_frame>Two Years</time_frame>
    <description>The investigators will measure pre post changes in Forced Vital Capacity (FVC) by spirometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1/FVC</measure>
    <time_frame>Two Years</time_frame>
    <description>The investigators will measure pre post changes in the ratio of Forced Expiratory Volume in 1 second and Forced Vital Capacity (FEV1/FVC) by spirometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive hyperemia-peripheral arterial tonometry (RH-PAT) (Endothelial dysfunction)</measure>
    <time_frame>Two Years</time_frame>
    <description>Endothelial dysfunction will be measured by reactive hyperemia-peripheral arterial tonometry (RH-PAT) and Pre and post comparison will be done pre post intervention changes will be assessed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Atherosclerosis [carotid intima-media thickness (cIMT)]</measure>
    <time_frame>Two Years</time_frame>
    <description>Atherosclerosis will be measured by ultrasound-assessed carotid intima-media thickness (cIMT) pre post intervention changes will be assessed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vascular stiffness [brachial artery distensibility (BAD) ]</measure>
    <time_frame>Two Years</time_frame>
    <description>Vascular stiffness will be measured by brachial artery distensibility (BAD) and pre post intervention changes will be compared</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarkers of immune dysfunction and inflammation</measure>
    <time_frame>Two Years</time_frame>
    <description>Pre and post intervention changes of activation status of macrophages, dendritic cells and T-cell proliferation will be compared</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Household Air Polution</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Lung Diseases</condition>
  <condition>Immune Dysfunction</condition>
  <arm_group>
    <arm_group_label>Improved cook stove</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators will conduct a pre-post intervention study to evaluate effectiveness of improved stoves and compare outcomes after two years</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Improved cook stove</intervention_name>
    <description>The investigators will conduct a pre-post intervention study to evaluate effectiveness of improved stoves and compare outcomes after two years</description>
    <arm_group_label>Improved cook stove</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1) aged between 25 and 65, 2) live in biomass using home with traditional stoves, 3)
        non-smoker and live with non-smokers, 4) exposed to &lt;5 Âµg/L of water arsenic,

        Exclusion Criteria:

        1) Any immune related illness or taking any prescription medication (particularly those
        that suppress or enhance immune function), and 2) any clinical events of CVD or lung
        disease, including stroke or coronary heart disease.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Yunus, MBBS, MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammad Yunus, MBBS, MSc.</last_name>
    <phone>008801713093872</phone>
    <email>myunus@icddrb.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Muhammad AH Chowdhury, MBBS, MPH</last_name>
    <phone>008801730357685</phone>
    <email>asheq.haider@icddrb.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>International Centre for Diarrhoeal Disease Research, Bangladesh</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2016</study_first_submitted>
  <study_first_submitted_qc>June 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>September 21, 2017</last_update_submitted>
  <last_update_submitted_qc>September 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data collected of the proposed study will be made fully available to any bonafide researcher. In general, the investigators will follow the data sharing plan developed and practiced by the NIH-funded grantees. Any data request by external researchers will be reviewed by the PIs and the AOC and the requested specific data will be made available to the through a secured web-based interface developed specifically for this project. In general, data will be made available six months after the manuscript reporting results from those specific sets of data are accepted for publication and all data requests will be processed within six months from the receipt of the request in writing. Any data requests with potential conflicts will be reviewed and decided by the AOC.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

